BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29101237)

  • 1. Human
    Li Y; Jin C; Bai H; Gao Y; Sun S; Chen L; Qin L; Liu PP; Cheng L; Wang QF
    Blood; 2018 Jan; 131(2):191-201. PubMed ID: 29101237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
    Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
    Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
    Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
    Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX1 and TGF-β signaling cross talk regulates Ca
    Raghuwanshi S; Dahariya S; Sharma DS; Kovuru N; Sahu I; Gutti RK
    FEBS J; 2020 Dec; 287(24):5411-5438. PubMed ID: 32281291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.
    Connelly JP; Kwon EM; Gao Y; Trivedi NS; Elkahloun AG; Horwitz MS; Cheng L; Liu PP
    Blood; 2014 Sep; 124(12):1926-30. PubMed ID: 25114263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
    Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
    PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells.
    Estevez B; Borst S; Jarocha D; Sudunagunta V; Gonzalez M; Garifallou J; Hakonarson H; Gao P; Tan K; Liu P; Bagga S; Holdreith N; Tong W; Speck N; French DL; Gadue P; Poncz M
    Blood; 2021 May; 137(19):2662-2675. PubMed ID: 33569577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model.
    Borst S; Nations CC; Klein JG; Pavani G; Maguire JA; Camire RM; Drazer MW; Godley LA; French DL; Poncz M; Gadue P
    Stem Cell Reports; 2021 Jun; 16(6):1458-1467. PubMed ID: 34019812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation.
    Wang C; Tu Z; Cai X; Wang W; Davis AK; Nattamai K; Paranjpe A; Dexheimer P; Wu J; Huang FL; Geiger H; Huang G; Zheng Y
    Blood Adv; 2023 Jun; 7(11):2590-2605. PubMed ID: 36661340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression.
    Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H
    Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.
    Lee K; Ahn HS; Estevez B; Poncz M
    Blood; 2023 Jan; 141(3):260-270. PubMed ID: 36219879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.
    Kuvardina ON; Herglotz J; Kolodziej S; Kohrs N; Herkt S; Wojcik B; Oellerich T; Corso J; Behrens K; Kumar A; Hussong H; Urlaub H; Koch J; Serve H; Bonig H; Stocking C; Rieger MA; Lausen J
    Blood; 2015 Jun; 125(23):3570-9. PubMed ID: 25911237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective RAB31-mediated megakaryocytic early endosomal trafficking of VWF, EGFR, and M6PR in RUNX1 deficiency.
    Jalagadugula G; Mao G; Goldfinger LE; Wurtzel J; Del Carpio-Cano F; Lambert MP; Estevez B; French DL; Poncz M; Rao AK
    Blood Adv; 2022 Sep; 6(17):5100-5112. PubMed ID: 35839075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
    Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
    J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
    Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
    Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets.
    Glembotsky AC; Bluteau D; Espasandin YR; Goette NP; Marta RF; Marin Oyarzun CP; Korin L; Lev PR; Laguens RP; Molinas FC; Raslova H; Heller PG
    J Thromb Haemost; 2014 May; 12(5):761-72. PubMed ID: 24606315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.
    Antony-Debré I; Manchev VT; Balayn N; Bluteau D; Tomowiak C; Legrand C; Langlois T; Bawa O; Tosca L; Tachdjian G; Leheup B; Debili N; Plo I; Mills JA; French DL; Weiss MJ; Solary E; Favier R; Vainchenker W; Raslova H
    Blood; 2015 Feb; 125(6):930-40. PubMed ID: 25490895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.
    Huang H; Woo AJ; Waldon Z; Schindler Y; Moran TB; Zhu HH; Feng GS; Steen H; Cantor AB
    Genes Dev; 2012 Jul; 26(14):1587-601. PubMed ID: 22759635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors.
    Draper JE; Sroczynska P; Leong HS; Fadlullah MZH; Miller C; Kouskoff V; Lacaud G
    Blood; 2017 Jul; 130(3):271-284. PubMed ID: 28490570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb.
    Goldfarb AN
    J Cell Biochem; 2009 Jun; 107(3):377-82. PubMed ID: 19350569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.